Nogi, Japan

Shizuyoshi Fujimori


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Tochigi, JP (1988)
  • Ooaza-Marubayashi, JP (1990)
  • Marubayashi, JP (1993)
  • Nogi, JP (1986 - 1994)
  • Nogi-machi, JP (2003)

Company Filing History:


Years Active: 1986-2003

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Shizuyoshi Fujimori: Innovator in Pharmaceutical Chemistry

Introduction

Shizuyoshi Fujimori is a notable inventor based in Nogi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work focuses on innovative compounds that have potential therapeutic applications.

Latest Patents

Fujimori's latest patents include the development of substituted benzylthiazolidine-2,4-dione derivatives and cyclic anthranilic acid derivatives. One of his notable inventions is an antirheumatoid pharmaceutical composition that contains a cyclic anthranilic acid derivative. This composition features a complex formula where various groups can be substituted, indicating a high level of specificity and potential efficacy in treating rheumatoid conditions.

Career Highlights

Fujimori is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new pharmaceutical solutions that address various health issues.

Collaborations

Fujimori has collaborated with esteemed colleagues such as Eisuke Kojima and Katsuya Awano. These partnerships have fostered a collaborative environment that enhances innovation and the development of new pharmaceutical products.

Conclusion

Shizuyoshi Fujimori's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His ongoing work promises to lead to significant advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…